Kenyan experts appointed to African Medicines Agency committees
Two Pharmacy and Poisons Board officials will serve two-year terms on AMA technical committees.
Kenya has secured two key roles on the African Medicines Agency (AMA) technical committees, with Edward Abwao elected chairperson of the committee overseeing clinical trials. The appointments of officials from the Pharmacy and Poisons Board (PPB) aim to harmonise medicines regulation across Africa and improve access to safe medical products. Dr Ali Abdulahi Arale was appointed to the committee that evaluates medicines, vaccines, and biologicals, while Edward Abwao joined the committee for clinical trials oversight and Good Clinical Practice.
These two-year appointments were announced in Kigali, Rwanda, during the AMA's inaugural week. PPB stated the roles recognise the experience of Kenya's medicines regulators and will strengthen the country's scientific and regulatory decision-making on the continent. Dr Arale brings over 25 years of experience in medicines regulation, including health product registration and emergency use authorization. Abwao has over 22 years of experience and helped establish Kenya’s clinical trials regulatory framework.
The committees provide independent scientific advice to AMA on medical product evaluation and clinical trial oversight. PPB said the participation of the Kenyan experts will foster continental regulatory cooperation and contribute to better access to quality-assured medical products across Africa. The AMA technical committees support evidence-based regulatory decisions and the harmonisation of standards among African countries.
Why it mattersKenyan citizens will benefit from improved access to safe and quality-assured medical products across Africa due to these appointments.